Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Pulmonx Corp | 28,800 | reported | 01 Mar 2024 | tx 11+93,633−2,020 |
| KalVista Pharmaceuticals, Inc. | 10,000 | reported | 04 Jan 2016 | tx 2+60,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Mar 2024 | SALE | Pulmonx Corp | 155 | 9.06 USD | |
| 01 Mar 2024 | GRANT_AWARD | Pulmonx Corp | 14,400 | 0.00 USD | |
| 01 Mar 2024 | SALE | Pulmonx Corp | 254 | 9.06 USD | |
| 01 Mar 2024 | SALE | Pulmonx Corp | 669 | 9.06 USD | |
| 01 Mar 2024 | GRANT_AWARD | Pulmonx Corp | 28,800 | 0.00 USD | deriv |
| 01 Dec 2023 | GRANT_AWARD | Pulmonx Corp | 7,233 | 0.00 USD | |
| 01 Dec 2023 | SALE | Pulmonx Corp | 585 | 10.34 USD | |
| 01 Dec 2023 | SALE | Pulmonx Corp | 222 | 10.34 USD | |
| 01 Dec 2023 | SALE | Pulmonx Corp | 135 | 10.33 USD | |
| 04 Jan 2016 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 02 Nov 2015 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |